Neuroblastoma metastatic to the central nervous system - The Memorial Sloan-Kettering Cancer Center experience and a literature review

被引:1
|
作者
Kramer, K
Kushner, B
Heller, G
Cheung, NKV
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
neuroblastoma; central nervous system metastases; lumbar punctures;
D O I
10.1002/1097-0142(20010415)91:8<1510::AID-CNCR1159>3.3.CO;2-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND, The central nervous system (CNS) can be a sanctuary site for cancer cells, because the blood-brain barrier impedes penetration of most chemotherapeutic agents. The authors hypothesized that, with improved survival from childhood metastatic neuroblastoma (NB), the incidence of CNS (intraparenchymal and leptomeningeal) spread may increase. They undertook this study to assess the frequency of CNS NB, to analyze risk factors and treatment options, and to review the literature. METHODS. The authors retrospectively analyzed all patients with metastatic NB who were treated on protocols N4, N5, N6, and N7 from 1980 to 1999 at Memorial. Sloan-Kettering Cancer Center (MSKCC), during which time there was an increase in the overall survival rate. RESULTS. Two hundred fifty-one patients with Stage 4 NB (Group 251) were studied, of which 127 (Group 127) were newly diagnosed patients who were treated initially at MSKCC. None had CNS NB at the time of diagnosis. Eleven patients developed documented CNS disease; 8 of these 11 recurrences were isolated in the CNS. For Group 127, the overall incidence rate of CNS NB was 6.3%, with an increase in incidence from N4-N5 to N6-N7 of from 1.7% to 11.7%. Seven patients had isolated CNS disease recurrences. Only lumbar punctures (LP) performed near the time of diagnosis in patients with known bone marrow involvement were associated with subsequent development of CNS disease. For the entire group of 251 patients, lumbar puncture at the time of diagnosis and elevated serum lactic dehydrogenase levels were prognostic. Among the larger series reported in the literature, CNS involvement from metastatic lesions was rare at the time of diagnosis and remained an uncommon complication. CONCLUSIONS. The incidence of CNS NB may be increasing. Because it is the sole site of disease recurrence in 64% of patients, the CNS may represent a sanctuary site for NB. CNS NB is associated with diagnostic lumbar punctures in patients with known bone marrow disease, raising the possibility that circulating or epidural microscopic tumor cells may seed the craniospinal axis. Cancer 2001;91: 1510-9. (C) 2001 American Cancer Society.
引用
下载
收藏
页码:1510 / 1519
页数:10
相关论文
共 50 条
  • [1] Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model
    Abrey, Lauren E.
    Ben-Porat, Leah
    Panageas, Katherine S.
    Yahalom, Joachim
    Berkey, Brian
    Curran, Walter
    Schultz, Christopher
    Leibel, Steven
    Nelson, Diana
    Mehta, Minesh
    DeAngelis, Lisa M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5711 - 5715
  • [2] Neuroblastoma in adolescents and adults: The memorial Sloan-Kettering experience
    Kushner, BH
    Kramer, K
    LaQuaglia, MP
    Modak, S
    Cheung, NKV
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (06): : 508 - 515
  • [3] Characteristics and Outcomes of Elderly Patients With Primary Central Nervous System Lymphoma The Memorial Sloan-Kettering Cancer Center Experience
    Ney, Douglas E.
    Reiner, Anne S.
    Panageas, Katherine S.
    Brown, Hayley S.
    DeAngelis, Lisa M.
    Abrey, Lauren E.
    CANCER, 2010, 116 (19) : 4605 - 4612
  • [4] Pancreatic Metastasectomy: The Memorial Sloan-Kettering Experience and a Review of the Literature
    Untch, Brian R.
    Allen, Peter J.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (01) : 28 - 30
  • [5] Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience
    Rocha, Flavio G.
    Matsuo, Kenichi
    Blumgart, Leslie H.
    Jarnagin, William R.
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (04) : 490 - 496
  • [6] Solitary, isolated metastatic disease to the kidney: Memorial Sloan-Kettering Cancer Center experience
    Adamy, Ari
    Von Bodman, Christian
    Ghoneim, Tarek
    Favaretto, Ricardo L.
    Bernstein, Melanie
    Russo, Paul
    BJU INTERNATIONAL, 2011, 108 (03) : 338 - 342
  • [7] Neuroblastoma and treatment-related myelodysplasia/leukemia: The Memorial Sloan-Kettering experience and a literature review
    Kushner, BH
    Cheung, NKV
    Kramer, K
    Heller, G
    Jhanwar, SC
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3880 - 3889
  • [8] Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience
    Hudis, C
    Seidman, A
    Raptis, G
    Fennelly, D
    Gilewski, T
    Baselga, J
    Theodoulou, M
    Sklarin, N
    Moynahan, M
    Surbone, A
    Currie, V
    Lebwohl, D
    Uhlenhopp, M
    Crown, J
    Norton, L
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 58 - 64
  • [9] Nipple-Sparing Mastectomy: Initial Experience at the Memorial Sloan-Kettering Cancer Center and a Comprehensive Review of Literature
    Garcia-Etienne, Carlos A.
    Cody, Hiram S., III
    Disa, Joseph J.
    Cordeiro, Peter
    Sacchini, Virgilio
    BREAST JOURNAL, 2009, 15 (04): : 440 - 449
  • [10] Radiation therapy for breast cancer (BC) with central nervous system (CNS) metastases: A contemporary experience at Memorial Sloan-Kettering Cancer Center (MSKCC).
    Morikawa, Aki
    Diab, Adi
    Patil, Sujata
    Forte, Victoria
    Blum, Brian
    Young, Robert J.
    Beal, Kathryn
    Hudis, Clifford
    Seidman, Andrew David
    McArthur, Heather L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)